FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2012/11/003127 [Registered on: 21/11/2012] Trial Registered Retrospectively
Last Modified On: 19/11/2012
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Drug 
Study Design  Randomized, Parallel Group, Active Controlled Trial 
Public Title of Study   A clinical trial to study the effects of adapalene, benzoyl peroxide, and benzoyl peroxide-clindamycin combination in patients having pimples. 
Scientific Title of Study   A Randomized, open label, active controlled, parallel group trial to compare the safety and efficacy of adapalene, benzoyl peroxide, and benzoyl peroxide-clindamycin combination in patients with acne vulgaris. 
Trial Acronym   
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Anuradha Dubey 
Designation  PG Student 
Affiliation  Peoples College of Medical Sciences and Research Centre 
Address  Department of Pharmacology, Peoples College of Medical Sciences and Research Centre, Bhanpur, Bhopal

Bhopal
MADHYA PRADESH
462037
India 
Phone  9926193059  
Fax    
Email  dranudubey999@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Hanmant Amane 
Designation  Associate Professr 
Affiliation  Peoples College of Medical Sciences and Research Centre 
Address  Department of Pharmacology, Peoples College of Medical Sciences and Research Centre, Bhanpur, Bhopal

Bhopal
MADHYA PRADESH
462037
India 
Phone  8717955345  
Fax    
Email  drhsamane25@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Dr Hanmant Amane 
Designation  Associate Professr 
Affiliation  Peoples College of Medical Sciences and Research Centre 
Address  Department of Pharmacology, Peoples College of Medical Sciences and Research Centre, Bhanpur, Bhopal

Bhopal
MADHYA PRADESH
462037
India 
Phone  8717955345  
Fax    
Email  drhsamane25@gmail.com  
 
Source of Monetary or Material Support  
Peoples college of medical sciences and research center 
 
Primary Sponsor  
Name  Peoples college of medical sciences 
Address  Bhanpur Bhopal 
Type of Sponsor  Private medical college 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Hanmant Amane  department of dermatology, PCMS  Bhanpur Bhopal
Bhopal
MADHYA PRADESH 
8717955345

drhsamane25@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Institutional Ethics Committee, Peoples college of medical sciences and research center  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  Mild to Moderate Acne vulgaris,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Intervention  Adapalene  0.1% thin film to be applied once daily at bed time for three months 
Comparator Agent  Benzoyl peroxide  2.5% thin film to be applied once daily at bed time for three months 
Comparator Agent  Benzoyl peroxide and clindamycin combination  2.5% and 1% thin film to be applied once daily at bed time for three months 
 
Inclusion Criteria  
Age From  12.00 Year(s)
Age To  30.00 Year(s)
Gender  Both 
Details  1. Healthy males, and non-pregnant females, aged 12-30 years with a clinical diagnosis of mild-moderate acne vulgaris.
2. Presence of Non-inflammatory lesions (comedones).
3. Presence of mild to moderate inflammatory lesions like papules and pustules (Grades 1 and 2).
 
 
ExclusionCriteria 
Details  1. Acne patients with ages below 12years, or above 30 years.
2. Pregnant and nursing females.
3. Presence of severe inflammatory lesions of acne like nodulo-cystic lesions (Grades 3 and 4).
4. Presence of any other skin condition that would interfere with the diagnosis and assessment of acne vulgaris, (eg-on the face-rosaceae, dermatitis).
5. Excessive facial hair (eg-beard) that would interfere with diagnosis or assessment of acne vulgaris.
6. History of hypersensitivity or allergy to these drugs.
7. Use of any other drug for the treatment of acne vulgaris within 2 months.
8. Patients on hormonal treatment.
9. Patient on drugs causing acne as a side effect.
 
 
Method of Generating Random Sequence   Computer generated randomization 
Method of Concealment   On-site computer system 
Blinding/Masking   Open Label 
Primary Outcome  
Outcome  TimePoints 
Acne severity index
Total acne lesion count 
Acne severity index and
Total acne lesion count will be assessed after 2 4 6 8 10 12 weeks. 
 
Secondary Outcome  
Outcome  TimePoints 
Acne severity index
Total acne lesion count 
12 weeks 
 
Target Sample Size   Total Sample Size="150"
Sample Size from India="150" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 4 
Date of First Enrollment (India)   15/11/2012 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="6"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Open to Recruitment 
Publication Details   Not Applicable 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Brief Summary   The present study is a randomized, open label, active controlled, parallel group trial comparing the efficacy and safety of Adapalene 0.1% , Benzoyl peroxide 2.5%, and  Benzoyl peroxide 2.5% -Clindamycin 1% combination daily at bed time for 3 months in 150 patients of acne vulgaris. The study will be conducted in Peoples college of medical sciences and research center, Bhopal, India. The primary outcome measures are acne severity index and total acne lesion count.  
Close